6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Current advances in research and clinical applications of PLGA-based nanotechnology.

      Expert Review of Molecular Diagnostics

      Absorbable Implants, Animals, Biocompatible Materials, Drug Delivery Systems, Humans, Lactic Acid, chemistry, Materials Testing, Nanoparticles, Nanotechnology, methods, Polyglycolic Acid, Tissue Engineering

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Co-polymer poly(lactic-co-glycolic acid) (PLGA) nanotechnology has been developed for many years and has been approved by the US FDA for the use of drug delivery, diagnostics and other applications of clinical and basic science research, including cardiovascular disease, cancer, vaccine and tissue engineering. This article presents the more recent successes of applying PLGA-based nanotechnologies and tools in these medicine-related applications. It focuses on the possible mechanisms, diagnosis and treatment effects of PLGA preparations and devices. This updated information will benefit to both new and established research scientists and clinical physicians who are interested in the development and application of PLGA nanotechnology as new therapeutic and diagnostic strategies for many diseases.

          Related collections

          Author and article information

          Journal
          19435455
          2701163
          10.1586/erm.09.15

          Comments

          Comment on this article